Electric field therapy + chemo shows promise against pancreatic cancer
Disease control
Recruiting now
This study tests a wearable device that creates electric fields (TTFields) combined with two chemotherapy drugs (gemcitabine and nab-paclitaxel) for people with pancreatic cancer that can be removed by surgery. Participants wear the device at least 18 hours daily and receive chem…
Phase: PHASE2 • Sponsor: Ashish Manne • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC